Efficacy and Safety of Jaktinib in Participants With Severe Novel Coronavirus Pneumonia(COVID-19)
Clinical trial NCT05702788 · WITHDRAWN
Trial details
- NCT number
- NCT05702788
- Sponsor
- Suzhou Zelgen Biopharmaceuticals Co.,Ltd
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-01
- Primary completion
- 2024-04-23
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.